The Limit of Limits: India’s Hurdles in Regulating Antimicrobial Pollution

  04 May 2022

In this CIDRAP-ASP report, we analyze the events surrounding the proposal and eventual removal of the limits, describing the issue of antibiotic pollution in India within the larger context of pharmaceutical demand and outsourcing of manufacture from high-income countries (HICs), the role of India as a competitive and necessary source of pharmaceuticals during the COVID-19 pandemic, criticisms raised about the antibiotic waste limits from diverse viewpoints and interests, and potential next steps for ensuring that the issue of environmental pollution remains in the foreground of all discussion about antibiotic innovation and manufacture.

Further reading: CIDRAP
Author(s): Natalie Vestin, MPH
Clean Environment  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed